ERBB2 and breast cancer: We have also established that MenaINV expression is significantly higher in metastatic primary breast tumors58, correlates with disease recurrence and outcome in breast cancer patients39 and correlates with TMEM, a prognostic marker for metastasis in ER + /HER2- breast cancer patients44, 48, 49, 50.